New draft monograph on Amiodarone Hydrochloride capsules (5-200 mg) available for public consultation
All stakeholders are invited to submit their comments on the new draft monographs on Amiodarone Hydrochloride capsules (5-200 mg) published in Issue 9 of the Pharmeuropa PaedForm consultation platform. Additional information is available on the EDQM website.
The closing date for
comments is 30 September 2024.
Users can register for free access to the Pharmeuropa PaedForm platform. For more information on how to create your account or use the website, please consult the User manual.